in the news...
NanoMedTrix awarded funding from John Pappajohn Entreprenurial Center
June 18, 2021: Grant supplements previous JPEC funds; will be used to generate preliminary data for new grant applications.
NanoMedTrix: UI Faculty Innovators Program success story
May 26, 2021: University of Iowa John Pappajohn Entreprenurial Center
NanoMedTrix went from winning pitch competitions to winning multi-million dollar grants, with a little help from JPEC's Faculty Innovators program.
Small packages: UI nanotechnology firm gets $2 million boost in fight against cancer
May 17, 2021: Corridor Business Journal / Katharine Carlon
Eastern Iowa corridor spinoff continues to validate the clinical significance of the novel theranostic.
NanoMedTrix awarded $25,000 as part of SBIR/STTR Outreach Program of Bioconnect Iowa (formerly Iowa Innovation Corporation).
March 8, 2021
The funding supplements the NIH Phase II award, in particular commercialization efforts related to establishing a clinical trial network.
UI spin-off NanoMedTrix awarded $2 million from National Cancer Institute.
March 3, 2021: University of Iowa College of Engineering release
The SBIR grant is designed to bring the technology beyond the theoretical phase and closer to clinical trials for the treatment of bladder cancer.
Corridor startup NanoMedTrix seeking new rounds of private funding following NIH Phase II award.
March 2, 2021: Clay and Milk, covering Iowa's startup, tech, and entreprenurial communities
New private capital investment matched with NIH Phase IIb would fund future clinical trials for novel bladder cancer therapeutic.
NanoMedTrix receives Judges' Choice award at Iowa Innovation Challenge Fall 2020 Elevator Pitch Competition.
December 1, 2020: University of Iowa John Pappajohn Entreprenurial Center
The competition brings funds and recognition to companies started by University of Iowa faculty and students.
NanoMedTrix awarded $25,000 as part of SBIR/STTR Outreach Program of Iowa Innovation Corporation.
September 5, 2019
The funding provides grant assistance for submission of an SBIR Phase II grant to the NCI for continued development of a novel bladder cancer therapeutic.
NanoMedTrix selected for participation in the NIH I-Corps(TM) program.
December 23, 2018
The startup "bootcamp" is an intensive 8 week program designed to help biotech entrepreneurs identify and reach out to potential customers, partners.
NanoMedTrix awarded $295,000 from National Cancer Institute.
September 7, 2018
The SBIR Phase I will evaluate the clinical and commercial potential of NanoMedTrix technology in the diagnosis and treatment of bladder cancer.
NanoMedTrix, UI research spinoff firm, wins first-of-its-kind grant. The goal is to help physicians make early detection of cancer.
August 7, 2013: University of Iowa Now
NanoMedTrix, a 2-year-old Coralville firm based upon University of Iowa research that may one day save lives by helping physicians identify bladder and colon cancers at early stages of development, recently received a grant that is the first of its kind.
UI research evolves into business The birth of NanoMedTrix.
NanoMedTrix is developing a product that would use nanoparticles, which are 1,000 times smaller than the width of a human hair, to help with diagnosing bladder and colon cancer.
NanoMedTRIX Awarded a prestigious NSF SBIR grant Phase I (2014-15)
NanoMedTRIX Awarded NSF SBIR grant Phase Ib (2014-15)
NanoMedTRIX Awarded a University of Iowa SBIR Matching grant (2015)
Internship Grant from Iowa Economic Development (Summer 2015)
Grant from Iowa Economic Development For SBIR Submission Award (2015)
DEMO Grant from Iowa Economic Development (2014)
GAP Grant from Iowa Economic Development/University of Iowa (2013)